Clinical Trials Directory

Trials / Completed

CompletedNCT01585389

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

Expression and Subcellular Localization of NEIL3 in Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Children's Oncology Group · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to brain tumors. PURPOSE: This research studies gene expression and location in samples from patients with brain tumors.

Detailed description

OBJECTIVES: * To determine the expression and subcellular localization of nei endonuclease VIII-like 3 (NEIL3) in brain tumors. OUTLINE: Tissue microarray samples are analyzed for NEIL3 expression and subcellular localization by immunohistochemical methods.

Conditions

Interventions

TypeNameDescription
GENETICgene expression analysis
GENETICgenetic linkage analysis
GENETICmicroarray analysis
OTHERimmunohistochemistry staining method
OTHERlaboratory biomarker analysis

Timeline

Start date
2012-04-01
Primary completion
2016-05-01
First posted
2012-04-25
Last updated
2016-05-18

Source: ClinicalTrials.gov record NCT01585389. Inclusion in this directory is not an endorsement.